Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

M C Arendrup, E Dzajic, R H Jensen, H K Johansen, P Kjaeldgaard, Inge Jenny Dahl Knudsen, L Kristensen, C Leitz, Lars Erik Lemming, L Nielsen, B Olesen, F S Rosenvinge, B L Røder, Henrik Carl Schønheyder

185 Citationer (Scopus)

Abstract

Significant changes in the management of fungaemia have occurred over the last decade with increased use of fluconazole prophylaxis, of empirical treatment and of echinocandins as first-line agents for documented disease. These changes may impact the epidemiology of fungaemia. We present nationwide data for Denmark from 2010 to 2011. A total of 1081 isolates from 1047 episodes were recorded in 995 patients. The numbers of patients, episodes and recovered isolates increased by 13.1%, 14.5% and 14.1%, respectively, from 2010 to 2011. The incidence rate was significantly higher in 2011 (10.05/100 000) than in 2010 (8.82/100 000), but remained constant in the age groups 0-79 years. The incidence rate was highest at the extremes of age and in males. Candida albicans accounted for 52.1% but declined during 2004-11 (p 0.0155). Candida glabrata accounted for 28% and increased during 2004-2011 (p 

Fingeraftryk

Dyk ned i forskningsemnerne om 'Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme'. Sammen danner de et unikt fingeraftryk.

Citationsformater